A Randomized, Multicenter, Open-label Study of Yondelis (ET-743 Ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 Weeks vs. q3 Weeks) in Subjects With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Following Treatment With an Anthracycline and Ifosfamide
Каталог · ЕАЭС
Клинические исследования и проекты
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · найдено 23
23 исследования
Завершено
Фаза II
Россия
Yondelis; Yondelis; Dexamethasone; Dexamethasone · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Завершено
Фаза III
Россия
Risperdal Consta; Placebo · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
A Randomized, Double-blind, Placebo-controlled Study to Explore the Efficacy and Safety of Risperidone Long-acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar 1 Disorder, With Open-label Extension
Завершено
Фаза II
Россия
JNJ-37822681; JNJ-37822681; JNJ-37822681; Olanzapine; Placebo · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of JNJ-37822681 Administered Twice Daily in Subjects With Schizophrenia